Humana/$HUM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Humana
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Ticker
$HUM
Sector
Primary listing
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
65,680
ISIN
US4448591028
Website
Humana Metrics
BasicAdvanced
$29B
17.19
$14.16
0.63
$3.54
1.45%
Price and volume
Market cap
$29B
Beta
0.63
52-week high
$406.46
52-week low
$212.45
Average daily volume
1.9M
Dividend rate
$3.54
Financial strength
Current ratio
1.908
Quick ratio
1.474
Long term debt to equity
71.76
Total debt to equity
77.075
Dividend payout ratio (TTM)
25.15%
Interest coverage (TTM)
5.77%
Profitability
EBITDA (TTM)
4,097
Gross margin (TTM)
15.12%
Net profit margin (TTM)
1.42%
Operating margin (TTM)
3.17%
Effective tax rate (TTM)
24.86%
Revenue per employee (TTM)
$1,830,000
Management effectiveness
Return on assets (TTM)
4.72%
Return on equity (TTM)
10.10%
Valuation
Price to earnings (TTM)
17.189
Price to revenue (TTM)
0.244
Price to book
1.65
Price to tangible book (TTM)
3.62
Price to free cash flow (TTM)
12.318
Free cash flow yield (TTM)
8.12%
Free cash flow per share (TTM)
1,976.05%
Dividend yield (TTM)
1.45%
Forward dividend yield
1.45%
Growth
Revenue change (TTM)
10.09%
Earnings per share change (TTM)
-12.24%
3-year revenue growth (CAGR)
11.19%
10-year revenue growth (CAGR)
9.04%
3-year earnings per share growth (CAGR)
-15.60%
10-year earnings per share growth (CAGR)
6.13%
3-year dividend per share growth (CAGR)
7.03%
10-year dividend per share growth (CAGR)
12.20%
What the Analysts think about Humana
Analyst ratings (Buy, Hold, Sell) for Humana stock.
Bulls say / Bears say
Humana's stock surged by 16% following a 5.06% increase in 2026 Medicare Advantage payment rates, significantly higher than the initially proposed 2.2%, enhancing profitability prospects. (reuters.com)
The company reported an adjusted profit of $4.16 per share in Q3 2024, surpassing analyst expectations of $3.40, driven by robust growth in its Medicare Advantage business. (reuters.com)
Analysts have raised their price targets for Humana, with RBC Capital increasing to $400 and Oppenheimer to $400, reflecting confidence in the company's growth prospects. (nasdaq.com)
Humana's shares dropped by 15% due to a downgrade in quality ratings for its Medicare Advantage plans, potentially reducing bonus payments by about $3 billion. (reuters.com)
The company projected a 2025 adjusted profit per share of approximately $16.25, below analyst estimates of $16.71, citing persistent high costs in its Medicare Advantage plans. (reuters.com)
Barclays highlighted that a 10% reduction in bonus members could lead to a decrease of approximately $2.50 in earnings per share for Humana, indicating significant earnings risk. (investing.com)
Data summarised monthly by Lightyear AI. Last updated on 7 Jun 2025.
Humana Financial Performance
Revenues and expenses
Humana Earnings Performance
Company profitability
Humana News
AllArticlesVideos
Humana Launches “Invite” Campaign to Inspire Active Aging Through Pickleball and Community Connection
Business Wire·2 days ago
Humana Recognizes 10 Inspiring Athletes Who Are Redefining What It Means to Age
Business Wire·1 week ago
athenahealth, Humana, and Your Health Closing Critical Gaps at the Point of Care While Reducing Administrative Burden on Clinicians
Business Wire·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Jun27
Humana
Dividend·Ex-dividend
Jul25
Humana
Dividend·Payment
$0.885Per share
FAQs
What’s the current market cap for Humana stock?
Humana (HUM) has a market cap of $29B as of June 20, 2025.
What is the P/E ratio for Humana stock?
The price to earnings (P/E) ratio for Humana (HUM) stock is 17.19 as of June 20, 2025.
Does Humana stock pay dividends?
Yes, the Humana (HUM) stock pays dividends to shareholders. As of June 20, 2025, the dividend rate is $3.54 and the yield is 1.45%. Humana has a payout ratio of 25.15% on a trailing twelve-month basis.
When is the next Humana dividend payment date?
The next Humana (HUM) dividend payment is scheduled for July 25, 2025.
What is the beta indicator for Humana?
Humana (HUM) has a beta rating of 0.63. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.